INR 20.96
(-4.86%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -2.37 Million INR | -211.4% |
2022 | 2.13 Million INR | 348.37% |
2021 | -858 Thousand INR | -10.86% |
2020 | -773.92 Thousand INR | 34.58% |
2019 | -1.18 Million INR | 27.82% |
2018 | -1.63 Million INR | -72.52% |
2017 | -950.05 Thousand INR | 51.62% |
2016 | -1.96 Million INR | -32.55% |
2015 | -1.48 Million INR | -28.07% |
2014 | -1.15 Million INR | -44.77% |
2013 | -799.03 Thousand INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -2.04 Million INR | -61.31% |
2023 Q4 | -1.26 Million INR | -267.83% |
2023 FY | -2.37 Million INR | -211.4% |
2023 Q1 | -259 Thousand INR | -110.18% |
2023 Q3 | -345 Thousand INR | 29.01% |
2023 Q2 | -486 Thousand INR | -87.64% |
2022 FY | 2.13 Million INR | 348.37% |
2022 Q1 | -48 Thousand INR | 77.25% |
2022 Q3 | -162 Thousand INR | 19.8% |
2022 Q2 | -202 Thousand INR | -320.83% |
2022 Q4 | 2.54 Million INR | 1669.75% |
2021 Q3 | -218 Thousand INR | 11.38% |
2021 Q4 | -211 Thousand INR | 3.21% |
2021 Q2 | -246 Thousand INR | -35.16% |
2021 Q1 | -182 Thousand INR | -83.99% |
2021 FY | -858 Thousand INR | -10.86% |
2020 Q3 | -482 Thousand INR | -7.83% |
2020 Q1 | -46 Thousand INR | 88.08% |
2020 FY | -773.92 Thousand INR | 34.58% |
2020 Q4 | -98.92 Thousand INR | 79.48% |
2020 Q2 | -447 Thousand INR | -871.74% |
2019 Q2 | -246 Thousand INR | 37.4% |
2019 FY | -1.18 Million INR | 27.82% |
2019 Q3 | -156 Thousand INR | 36.59% |
2019 Q1 | -393 Thousand INR | 48.16% |
2019 Q4 | -385.99 Thousand INR | -147.43% |
2018 Q2 | -205 Thousand INR | 43.21% |
2018 FY | -1.63 Million INR | -72.52% |
2018 Q1 | -361 Thousand INR | -1062.45% |
2018 Q3 | -315 Thousand INR | -53.66% |
2018 Q4 | -758.04 Thousand INR | -140.65% |
2017 Q1 | -168 Thousand INR | 71.9% |
2017 Q2 | -173 Thousand INR | -2.98% |
2017 Q4 | -31.05 Thousand INR | 94.63% |
2017 Q3 | -578 Thousand INR | -234.1% |
2017 FY | -950.05 Thousand INR | 51.62% |
2016 Q2 | -464 Thousand INR | 13.43% |
2016 Q1 | -536 Thousand INR | -56.49% |
2016 FY | -1.96 Million INR | -32.55% |
2016 Q4 | -597.8 Thousand INR | -63.34% |
2016 Q3 | -366 Thousand INR | 21.12% |
2015 Q4 | -342.52 Thousand INR | 3.79% |
2015 FY | -1.48 Million INR | -28.07% |
2015 Q3 | -356 Thousand INR | 11.0% |
2015 Q2 | -400 Thousand INR | -4.44% |
2015 Q1 | -383 Thousand INR | 17.42% |
2014 Q2 | -321 Thousand INR | -64.62% |
2014 Q3 | -177 Thousand INR | 44.86% |
2014 Q4 | -463.78 Thousand INR | -162.02% |
2014 FY | -1.15 Million INR | -44.77% |
2014 Q1 | -195 Thousand INR | 6.72% |
2013 Q4 | -209.03 Thousand INR | -16.78% |
2013 Q3 | -179 Thousand INR | -4.68% |
2013 Q2 | -171 Thousand INR | 0.0% |
2013 FY | -799.03 Thousand INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Alfavision Overseas (India) Limited | 2.76 Million INR | 185.89% |
Biocon Limited | 10.22 Billion INR | 100.023% |
Blue Jet Healthcare Limited | 1.63 Billion INR | 100.145% |
Concord Biotech Limited | 3.08 Billion INR | 100.077% |
Dishman Carbogen Amcis Limited | -1.53 Billion INR | 99.845% |
FERMENTA BIOTECH LIMITED | -230.59 Million INR | 98.971% |
GENOMIC VALLEY BIOTECH LIMITED | 151.81 Thousand INR | 1663.714% |
Lyka Labs Limited | -24.89 Million INR | 90.464% |
Panacea Biotec Limited | -11.73 Million INR | 79.761% |
SAMSRITA LABS LIMITED | -2.62 Million INR | 9.474% |
SMS Lifesciences India Limited | 90.92 Million INR | 102.611% |
Supriya Lifescience Limited | 1.19 Billion INR | 100.199% |
Syngene International Limited | 5.1 Billion INR | 100.047% |
TAKE Solutions Limited | -1.19 Billion INR | 99.802% |
Titan Biotech Limited | 248.53 Million INR | 100.955% |
Transgene Biotek Limited | -6.55 Million INR | 63.783% |
Vanta Bioscience Limited | -23.15 Million INR | 89.749% |